MENU
+Compare
ASMB
Stock ticker: NASDAQ
AS OF
Dec 20, 04:59 PM (EDT)
Price
$15.13
Change
-$0.68 (-4.30%)
Capitalization
96.17M

ASMB Assembly Biosciences Forecast, Technical & Fundamental Analysis

a manufacturer of phamaceutical products

Industry Biotechnology
ASMB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for ASMB with price predictions
Dec 20, 2024

ASMB's Indicator enters downward trend

The Aroon Indicator for ASMB entered a downward trend on December 20, 2024. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 256 similar instances where the Aroon Indicator formed such a pattern. In of the 256 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 11, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on ASMB as a result. In of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ASMB turned negative on December 11, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

ASMB moved below its 50-day moving average on December 10, 2024 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ASMB crossed bearishly below the 50-day moving average on December 11, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ASMB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ASMB's RSI Indicator exited the oversold zone, of 37 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 59 cases where ASMB's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ASMB advanced for three days, in of 257 cases, the price rose further within the following month. The odds of a continued upward trend are .

ASMB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.717) is normal, around the industry mean (14.556). P/E Ratio (0.000) is within average values for comparable stocks, (87.563). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.739). ASMB has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (3.061) is also within normal values, averaging (256.215).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ASMB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ASMB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ASMB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ASMB is expected to report earnings to fall 85.84% to -23 cents per share on March 07

Assembly Biosciences ASMB Stock Earnings Reports
Q4'23
Est.
$-0.23
Q1'24
Missed
by $1.39
Q3'23
Missed
by $0.03
Q2'23
Missed
by $0.04
Q1'23
Missed
by $0.02
The last earnings report on May 09 showed earnings per share of -165 cents, missing the estimate of -27 cents. With 30.66K shares outstanding, the current market capitalization sits at 96.17M.
A.I. Advisor
published General Information

General Information

a manufacturer of phamaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
Two Tower Place
Phone
+1 833 509-4583
Employees
65
Web
https://www.assemblybio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SQZB0.03N/A
N/A
SQZ Biotechnologies Company
RTMVY16.48-0.07
-0.42%
Rightmove Plc
JRONY37.66-0.17
-0.45%
Jeronimo Martins, SGPS, SA
IFNNY32.71-0.23
-0.70%
Infineon Technologies AG
IVCTF0.04N/A
-2.50%
INVICTUS ENERGY LTD.

ASMB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ASMB has been loosely correlated with SPRC. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ASMB jumps, then SPRC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASMB
1D Price
Change %
ASMB100%
-3.80%
SPRC - ASMB
45%
Loosely correlated
-0.19%
NKTX - ASMB
42%
Loosely correlated
+7.73%
ORMP - ASMB
33%
Loosely correlated
-4.82%
INZY - ASMB
32%
Poorly correlated
+6.41%
UBX - ASMB
32%
Poorly correlated
-1.04%
More